News for 'Sun Pharma'

Earnings winter to persist in Q4

Earnings winter to persist in Q4

Rediff.com23 Apr 2025

Brokerages expect a further slowdown in Indian firms' revenue and earnings growth in Q4FY25, following low single-digit growth in the preceding three quarters, as factors like weak consumer demand and credit growth linger on.

Trump Tariffs: Time To Rejig Portolio

Trump Tariffs: Time To Rejig Portolio

Rediff.com4 Apr 2025

Investors should tilt their portfolios towards domestic-facing defensive sectors, which should help provide stability and shield them from geopolitical and tariff risks.

Equity markets likely to trade in positive territory on Friday

Equity markets likely to trade in positive territory on Friday

Rediff.com10 Apr 2025

Domestic benchmark equity indices may see a positive trading sentiment on Friday thanks to a spectacular rally in world markets after the US President Donald Trump announced to put tariff hikes on hold for 90 days, excluding China from the reprieve. Indian stock markets were closed on Thursday for Shri Mahavir Jayanti. Trump has declared a three-month pause on reciprocal tariffs on non-retaliating countries marking a rather unexpected U-turn after record high levies he imposed led to global stock market meltdown.

Trump's Tariff War: India Waits, Watches

Trump's Tariff War: India Waits, Watches

Rediff.com3 Feb 2025

'We have to be prepared for the larger disruption that is likely to take place.'

Missed The IPO Bus? Read This

Missed The IPO Bus? Read This

Rediff.com1 Apr 2025

For investors who missed the initial IPO frenzy, the market correction is an opportunity to selectively invest in promising names, but patience and careful evaluation remain the key.

Banking, FMCG, pharma shares drag Sensex down 366 points

Banking, FMCG, pharma shares drag Sensex down 366 points

Rediff.com11 Aug 2023

From the Sensex pack, IndusInd Bank, NTPC, Asian Paints, Hindustan Unilever, JSW Steel, Tech Mahindra, Bajaj Finance, Infosys, Wipro, ICICI Bank, Bajaj Finserv, HDFC Bank and Tata Motors were among the major laggards. HCL Technologies, Power Grid, Titan, Reliance Industries, UltraTech Cement, Tata Steel, State Bank of India and Mahindra & Mahindra were the gainers.

US tariffs: India not in a hurry, to follow wait and watch approach

US tariffs: India not in a hurry, to follow wait and watch approach

Rediff.com3 Apr 2025

The official said there are both challenges and opportunities for India as many of its competitor countries in exports, such as China Vietnam, Bangladesh, Cambodia and Thailand, face higher duties.

Stock markets settle flat in muted trade

Stock markets settle flat in muted trade

Rediff.com26 Dec 2024

From the 30 blue-chip stocks, Titan, Asian Paints, Nestle, Tech Mahindra, Reliance Industries, Zomato, Larsen & Toubro and Bajaj Finserv were among the laggards. Adani Ports, Mahindra & Mahindra, Maruti, Sun Pharma, Bharti Airtel and Tata Motors were among the gainers.

Sensex sinks 425 points dragged by auto stocks, foreign fund outflows

Sensex sinks 425 points dragged by auto stocks, foreign fund outflows

Rediff.com21 Feb 2025

Equity benchmark indices Sensex and Nifty ended lower on Friday, dragged by auto stocks and relentless foreign fund outflows. Weak US markets and tariff threats also dented investor sentiment. The 30-share BSE benchmark Sensex dropped 424.90 points or 0.56 per cent to settle at 75,311.06.

India sees record deal activity in Feb at $7.2 bn

India sees record deal activity in Feb at $7.2 bn

Rediff.com15 Mar 2025

India witnessed a record-breaking surge in deal activity in February, with 226 M&A and private equity deals totaling $7.2 billion -- the highest monthly deal volume in the last three years, according to the Dealtracker report of Grant Thornton Bharat. "This represents a 67 per cent increase in volumes and a 5.4-fold increase in values compared to February 2024, while a 14 per cent increase over the previous month," it said.

Pharma export body suspends Marion Biotech for no reply on syrup deaths

Pharma export body suspends Marion Biotech for no reply on syrup deaths

Rediff.com30 Dec 2022

The drug maker will lose some incentives if its membership is suspended, sources in Pharmexcil said.

Markets end marginally lower in volatile trade

Markets end marginally lower in volatile trade

Rediff.com19 Feb 2025

From the Sensex pack, Tata Consultancy Services and Infosys fell over 2 per cent each. Hindustan Unilever, Bharti Airtel, Sun Pharma, Power Grid, Bajaj Finserv, HCL Tech, Mahindra & Mahindra, and Tech Mahindra were also among the laggards. Among the gainers, Zomato jumped nearly 5 per cent. Larsen & Toubro, Axis Bank, ICICI Bank, IndusInd Bank and Kotak Mahindra Bank were also among the gainers.

Aurbindo Pharma ranks 2nd among Indian's pharma cos

Aurbindo Pharma ranks 2nd among Indian's pharma cos

Rediff.com20 Feb 2018

With sales of over Rs 12,240 crore in nine months of the current financial year, it is ahead of Rs 11,580 crore recorded by Lupin but behind Sun Pharma, which reported Rs 19,350 crore sales.

Trump's Tariffs: India Should Be Worried

Trump's Tariffs: India Should Be Worried

Rediff.com4 Apr 2025

While growth in India is largely domestic and hence the overall GDP effect may not be more than 0.15-0.2%, but overall trade will be impacted due to every country going back to the drawing board, points out Madan Sabnavis.

Dabba Cartel Review: High Five!

Dabba Cartel Review: High Five!

Rediff.com28 Feb 2025

Dabba Cartel's reluctant black comedy in the body of a crime thriller starts out interestingly enough to accomplish its Narcos: Thane aspirations, notes Sukanya Verma.

Sensex, Nifty tank nearly 1% on selloff in banking, IT stocks

Sensex, Nifty tank nearly 1% on selloff in banking, IT stocks

Rediff.com3 Jan 2025

From the Sensex pack, Zomato, HDFC Bank, Tech Mahindra, Adani Ports, Tata Consultancy Services, ICICI Bank, Sun Pharma, Larsen & Toubro, HCL Tech and ITC were the major laggards. On the other hand, Tata Motors, Nestle, Titan, Hindustan Unilever and Reliance Industries were among the gainers.

Markets open higher ahead of Budget presentation

Markets open higher ahead of Budget presentation

Rediff.com1 Feb 2025

From the 30-share blue-chip pack, ITC Hotels, IndusInd Bank, Mahindra & Mahindra, Sun Pharma, UltraTech Cement and NTPC were among the biggest gainers. Titan, Kotak Mahindra Bank, Nestle, Asian Paints, HCL Tech and ICICI Bank were among the laggards.

Trump's tariffs: How will these sectors in India be impacted?

Trump's tariffs: How will these sectors in India be impacted?

Rediff.com2 Apr 2025

Goods from sectors, including agriculture, precious stones, chemicals, pharma, medical devices, electricals, and machinery may get impacted if the US will go ahead with imposing reciprocal tariffs on Indian products, according to experts. They said that these sectors could face additional customs duties from the Trump administration because of the high tariff differential or gap, which is the difference between the import duties imposed by the US and India on a product.

Sensex, Nifty surge nearly 2% on buying in financial, IT stocks

Sensex, Nifty surge nearly 2% on buying in financial, IT stocks

Rediff.com2 Jan 2025

From 30 Sensex shares, Bajaj Finserv jumped nearly 8 per cent while Bajaj Finance soared over 6 per cent. Maruti, Titan, Mahindra, Mahindra & Mahindra, Infosys, HCL Tech, Zomato, UltraTech Cement and Kotak Mahindra Bank were the other major gainers. Sun Pharma emerged as the only laggard.

India gets ready to face possible fallout of US tariffs

India gets ready to face possible fallout of US tariffs

Rediff.com1 Apr 2025

The commerce ministry is working on different scenarios to assess the possible fallout of reciprocal tariffs to be imposed by the US administration on April 2 on its key trading partners including India, sources said. US President Donald Trump has said that April 2 will be 'Liberation Day' as he plans to announce tariffs or import duties to bring down America's trade deficit, and promote the country's manufacturing.

Relentless FII selling hits market sentiments; Sensex down 200 points

Relentless FII selling hits market sentiments; Sensex down 200 points

Rediff.com14 Feb 2025

From the 30-share blue-chip pack, Adani Ports dropped over 4 per cent. UltraTech Cement, Sun Pharma, IndusInd Bank, NTPC and Tata Steel were also the among the laggards. Nestle, ICICI Bank, Infosys, Tata Consultancy Services and HCL Tech were among the gainers.

Sensex drops 138 points on foreign fund outflow

Sensex drops 138 points on foreign fund outflow

Rediff.com23 Oct 2024

Sensex drops 138 points on foreign fund outflow

Chandrababu Meets Victims Of Explosion

Chandrababu Meets Victims Of Explosion

Rediff.com23 Aug 2024

On Wednesday, August 21, 2024, 17 persons were killed and 33 hurt when a major fire and explosion ripped through a pharma unit at a company in Atchutapuram SEZ, Anakapalle, Visakhapatnam.

Markets crash 1.6%; Sensex tanked 1,258 points

Markets crash 1.6%; Sensex tanked 1,258 points

Rediff.com6 Jan 2025

From the 30-share blue-chip pack, Tata Steel, NTPC, Kotak Mahindra Bank, IndusInd Bank, Power Grid, Zomato, Adani Ports, Asian Paints, Mahindra & Mahindra and Reliance Industries were among the biggest laggards. Titan and Sun Pharma were the only gainers.

'Investors: Stay Calm. Avoid Speculative Investment Behaviour'

'Investors: Stay Calm. Avoid Speculative Investment Behaviour'

Rediff.com8 Apr 2025

'My advice: Don't mark your portfolio to market every day. Focus on survival.'

Sensex pares intra-day high to end up 598 points

Sensex pares intra-day high to end up 598 points

Rediff.com3 Dec 2024

From the 30-share Sensex pack, Adani Ports surged nearly 6 per cent. NTPC, Axis Bank, State Bank of India, Larsen & Toubro, UltraTech Cement, Tata Motors, HDFC Bank and Reliance Industries were the other big gainers. Bharti Airtel, ITC, Sun Pharma, Asian Paints and Kotak Mahindra Bank were the laggards.

Exports contracts; trade deficit widens to $23 bn

Exports contracts; trade deficit widens to $23 bn

Rediff.com17 Feb 2025

eclined for the third month in a row in January, falling by 2.38 per cent year-on-year to $36.43 billion, while the trade deficit widened to $22.99 billion in the month. Imports rose by 10.28 per cent year-on-year to $59.42 billion in January due to an increase gold shipments, according to the Commerce Ministry data. The trade deficit was $21.94 billion in December and $16.55 billion in January last year.

Markets end in red on surging crude prices, FII outflows

Markets end in red on surging crude prices, FII outflows

Rediff.com10 Jan 2025

From the 30-share blue-chip pack, IndusInd Bank, NTPC, UltraTech Cement, Sun Pharma, Axis Bank, State Bank of India, Tata Steel, Power Grid, Adani Ports and Kotak Mahindra Bank were among the major laggards. Tata Consultancy Services jumped nearly 6 per cent after the IT services company reported an 11.95 per cent jump in the December quarter net profit to Rs 12,380 crore. Tech Mahindra, HCL Tech, Infosys and Bajaj Finserv were the other big gainers.

Pharma stocks make a comeback as Covid cases surge

Pharma stocks make a comeback as Covid cases surge

Rediff.com20 Apr 2021

However, experts caution that investors should not expect the big returns they got from the sector between March and September 2020.

Will Indian exporters gain from US-China trade war?

Will Indian exporters gain from US-China trade war?

Rediff.com4 Feb 2025

The trade war between the US and China is expected to benefit Indian exporters in increasing their shipments to the American market, sources said. They said the country was the fourth-largest gainer when the US imposed higher duties on Chinese goods during US President Donald Trump's first tenure.

Modi raises anti-India activities in NZ with visiting PM

Modi raises anti-India activities in NZ with visiting PM

Rediff.com17 Mar 2025

India and New Zealand have signed a pact to institutionalize their defence ties and vowed to boost cooperation in the Indo-Pacific. Prime Minister Narendra Modi raised concerns about anti-India activities by some illegal elements in New Zealand with his Kiwi counterpart Christopher Luxon. The two sides also signed six agreements to enhance cooperation in areas including education, sports, agriculture, and climate change. They also agreed to prepare a roadmap for cooperation in the defence industry sector and explore early implementation of cooperation in the digital payments sector.

What Trump Tariffs Can India Expect On April 2?

What Trump Tariffs Can India Expect On April 2?

Rediff.com26 Mar 2025

'As negotiations continue, the path forward demands not only diplomatic skill, but also vigilance against legal asymmetries embedded in America's trade playbook.'

SRK, Sachin Hug At Swearing In

SRK, Sachin Hug At Swearing In

Rediff.com5 Dec 2024

Mukesh Ambani, accompanied by younger son Anant and younger daughter-in-law Radhika Merchant Ambani, were among the many celebrities who attended Devendra Fadnavis' swearing in at Azad Maidan on Thursday afternoon.

How Much Have MFs Invested In HDFC Bank?

How Much Have MFs Invested In HDFC Bank?

Rediff.com16 Aug 2024

With a deployment of Rs 2,720 crore in July, MFs' total investment in HDFC Bank in calendar year 2024 (till now) surged to Rs 48,820 crore.

GDP growth projection spooks markets; Sensex down 51 points

GDP growth projection spooks markets; Sensex down 51 points

Rediff.com8 Jan 2025

From the 30-share blue-chip pack, Adani Ports, UltraTech Cement, Larsen & Toubro, Sun Pharma, HDFC Bank, ICICI Bank, NTPC and State Bank of India were the major laggards. Tata Consultancy Services, Reliance Industries, ITC, Asian Paints, HCL Tech and Maruti were among the gainers.

Sun Pharma recalls over 34k bottles of generic drug in US

Sun Pharma recalls over 34k bottles of generic drug in US

Rediff.com11 Feb 2023

Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing. As per the US Food and Drug Administration's Enforcement Report, the US-based arm of Sun Pharmaceutical Industries is recalling lots of Diltiazem Hydrochloride extended-release capsules which are used to treat angina, high blood pressure and some types of irregular heartbeats.

Siemens stock drops rapidly as management flags growth challenges ahead

Siemens stock drops rapidly as management flags growth challenges ahead

Rediff.com31 Dec 2024

Siemens's share price has lost ground in the past few sessions following weak management commentary. The management indicated challenges to the growth outlook due to stagnant private capex and concerns over semiconductor shortages for digital industries. Government infra-spending may regain momentum from January 2025.

NCB busts online pharma racket to send narcotics to US

NCB busts online pharma racket to send narcotics to US

Rediff.com8 May 2022

The pharmacy, identified by the federal anti-narcotics agency as JR Infinity Pvt Ltd, was located at Domalguda in Telangana's capital city.

FDI inflows jump 47.8% to $16.17 bn in Q1

FDI inflows jump 47.8% to $16.17 bn in Q1

Rediff.com3 Sep 2024

Foreign direct investment in India jumped 47.8 per cent to $16.17 billion in April-June this fiscal on healthy inflows in services, computer, telecom and pharma sectors, according to government data. FDI inflows were at $10.94 billion in April-June 2023-24. The data showed that overseas inflows in May rose to $5.85 billion and in June to $5.41 billion from $2.67 billion and $3.16 billion, respectively, in the year-ago period.

Bengaluru leads as top job hub with 9.3% salary growth: Report

Bengaluru leads as top job hub with 9.3% salary growth: Report

Rediff.com24 Oct 2024

Bengaluru dominated as the country's top city for job opportunities and salary growth as it has registered a 9.3 per cent year-on-year increase, closely followed by Chennai and Delhi, a report said on Thursday. This growth underlines Bengaluru's reputation as a technology and business hub as the average monthly unified salary in the city stood at Rs 29,500, making it the highest-paying city in the country, according to TeamLease Services Jobs and Salaries Primer report for FY24. The report is based on an analysis of unified salaries across temporary and permanent hiring markets.